Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
NCT06309238

Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial

Led by Carsten Dirksen · Updated on 2026-02-11

500

Participants Needed

10

Research Sites

1281 weeks

Total Duration

On this page

Sponsors

C

Carsten Dirksen

Lead Sponsor

U

University of Copenhagen

Collaborating Sponsor

AI-Summary

What this Trial Is About

With this trial, the aim is to assess the benefits and harms of a non-surgical intensive weight loss intervention that includes total dietary replacements, behavioural support and weight-loss medication compared with bariatric surgery for people with severe and complex obesity. The interpretation of the results will help inform future care pathways for people with obesity in whom bariatric surgery is currently the only available effective treatment option.

CONDITIONS

Official Title

Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 to 60 years (inclusive) at time of screening.
  • Eligible for and willing to undergo bariatric surgery, meeting national criteria: For Denmark, BMI ≥35 kg/m2 with related conditions or BMI >40 kg/m2 with strong medical reasons; for the UK, BMI 35-40 kg/m2 with other significant disease or BMI ≥40 kg/m2.
  • Fit for anesthesia and surgery.
  • Provided informed consent.
Not Eligible

You will not qualify if you...

  • Prior bariatric or hiatal surgery, except if intragastric balloons or duodenal-jejunal bypass sleeve removed more than 1 year before screening.
  • Use of any weight loss medication within the last 3 months.
  • Conditions contraindicating total diet replacement, including type 1 diabetes or insulin-requiring diabetes, phenylketonuria, or other special diet needs.
  • Conditions contraindicating treatment with GLP-1 receptor analogues, including history of pancreatitis or allergies.
  • Conditions contraindicating bariatric surgery, such as GI motility disorders, large abdominal wall or hiatus hernias, Crohn’s disease, liver cirrhosis, or multiple previous abdominal surgeries.
  • Conditions affecting study adherence or surgery, including mental disorders, unstable psychiatric disease, recent substance abuse, or cancer treatment within 5 years.
  • Pregnant, planning pregnancy within 2 years, or breastfeeding.
  • Not achieving 5% weight loss within 12 weeks before randomization.
  • Participation in other multidisciplinary obesity treatment research.
  • Another household member enrolled in the trial.
  • Diagnosis or treatment for severe eating disorder within the last 6 months.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

Steno Diabetes Center Aarhus, Aarhus Universitets Hospital

Aarhus, Denmark, 8200

Actively Recruiting

2

The Department of Medicine and Department of Surgery, University Hospital of South West Jutland

Esbjerg, Denmark, 6700

Actively Recruiting

3

The Department of Medicine and the Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre

Hvidovre, Denmark, 2650

Actively Recruiting

4

Department of Surgery, Viborg Regional Hospital

Viborg, Denmark, 8800

Actively Recruiting

5

St Richard's Hospital

Chichester, Sussex, United Kingdom, PO19 6SE

Actively Recruiting

6

Hartlands Hospital, University Hospitals Birmingham NHS Foundation Trust

Birmingham, United Kingdom, B9 5SS

Actively Recruiting

7

Southmead Hospital, North Bristol NHS Trust

Bristol, United Kingdom, BS10 5NB

Actively Recruiting

8

The Whittington Hospital

London, United Kingdom, N19 5NF

Actively Recruiting

9

Sunderland Royal Hospital

Sunderland, United Kingdom, SR4 7TP

Actively Recruiting

10

Musgrove Park Hospital, Somerset Foundation NHS Trust

Taunton, United Kingdom, TA1 5DA

Actively Recruiting

Loading map...

Research Team

K

Kirstine N Bojsen-Møller, MD, PhD

CONTACT

S

Susan Jebb, Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here